Taris Biomedical, a Lexington, MA-based developer of drug-device combo products for bladder conditions, reported this morning that it has hired Sarma Duddu to be its president and chief executive. Duddu was most recently a general manager and vice president of drug delivery at Cima Labs, a subsidiary of the Frazer, PA-based drugmaker Cephalon (NASDAQ:[[ticker:CEPH]]). In December, Luke wrote that the MIT spinoff Taris was in mid-stage clinical trials for a drug delivery device and treatment for painful bladder syndrome.
Author: Ryan McBride
Ryan is an award-winning business journalist who contributes to our life sciences and technology coverage. He was previously a staff writer for Mass High Tech, a Boston business and technology newspaper, where he and his colleagues won a national business journalism award from the Society of American Business Editors and Writers in 2008. In recent years, he has made regular TV appearances on New England Cable News.
Prior to MHT, Ryan covered the life sciences, technology, and energy sectors for Providence Business News. He graduated with honors from the University of Rhode Island in 2001 with a bachelor’s degree in communications. When he’s not chasing down news, Ryan enjoys mountain biking and skiing in his home state of Vermont.
View all posts by Ryan McBride
